Sign up to save your podcasts
Or
Share E55: Anifrolumab for SLE (TULIP 1&2)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E55: Anifrolumab for SLE (TULIP 1&2)
This week I talk about the recently published TULIP 1 and TULIP 2 trials that assessed anifrolumab for active SLE. Great to see a new drug in this disease state; interesting to think through how these trials played out. Get the papers and the pod at ebrheum.com and follow me @ebrheum if you'd like to share feedback!
View all episodes
By Michael Putman
4.9
111111 ratings
This week I talk about the recently published TULIP 1 and TULIP 2 trials that assessed anifrolumab for active SLE. Great to see a new drug in this disease state; interesting to think through how these trials played out. Get the papers and the pod at ebrheum.com and follow me @ebrheum if you'd like to share feedback!
More shows like The Evidence Based Rheumatology Podcast
View all
NEJM This Week
315 Listeners
JAMA Clinical Reviews
497 Listeners
Rheumnow Podcast
124 Listeners
The Curbsiders Internal Medicine Podcast
3,323 Listeners
Core IM | Internal Medicine Podcast
1,103 Listeners
Healio Rheuminations
119 Listeners
Annals On Call Podcast
195 Listeners
The Clinical Problem Solvers
516 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
349 Listeners
Freely Filtered, a NephJC Podcast
168 Listeners
ACR on Air
70 Listeners
Around the Rheum
4 Listeners
Rheumatology For The Royal College
174 Listeners
Talking Rheumatology Spotlight
6 Listeners
ACR Journals On Air
19 Listeners